ATE229510T1 - 2,3,4,5-tetrahydro-1h-3-benzazepinen mit anti- psychotisch wirkung, und synthese von alfa- substituierten-arylacetamiden - Google Patents

2,3,4,5-tetrahydro-1h-3-benzazepinen mit anti- psychotisch wirkung, und synthese von alfa- substituierten-arylacetamiden

Info

Publication number
ATE229510T1
ATE229510T1 AT93906034T AT93906034T ATE229510T1 AT E229510 T1 ATE229510 T1 AT E229510T1 AT 93906034 T AT93906034 T AT 93906034T AT 93906034 T AT93906034 T AT 93906034T AT E229510 T1 ATE229510 T1 AT E229510T1
Authority
AT
Austria
Prior art keywords
substituted
alpha
pct
benzazepines
hydrogen atoms
Prior art date
Application number
AT93906034T
Other languages
English (en)
Inventor
Joel G Berger
Wei K Chang
Joseph A Kozlowski
Guowei Zhou
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE229510T1 publication Critical patent/ATE229510T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
AT93906034T 1992-02-25 1993-02-23 2,3,4,5-tetrahydro-1h-3-benzazepinen mit anti- psychotisch wirkung, und synthese von alfa- substituierten-arylacetamiden ATE229510T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/841,603 US5241065A (en) 1992-02-25 1992-02-25 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
PCT/US1993/001425 WO1993016997A1 (en) 1992-02-25 1993-02-23 2,3,4,5-TETRAHYDRO-1H^_-3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF α-SUBSTITUTED-ARYLACETAMIDES

Publications (1)

Publication Number Publication Date
ATE229510T1 true ATE229510T1 (de) 2002-12-15

Family

ID=25285279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93906034T ATE229510T1 (de) 1992-02-25 1993-02-23 2,3,4,5-tetrahydro-1h-3-benzazepinen mit anti- psychotisch wirkung, und synthese von alfa- substituierten-arylacetamiden

Country Status (12)

Country Link
US (2) US5241065A (de)
EP (1) EP0628030B1 (de)
JP (1) JPH07504196A (de)
AT (1) ATE229510T1 (de)
AU (1) AU3722193A (de)
CA (1) CA2130797C (de)
DE (1) DE69332559T2 (de)
ES (1) ES2183810T3 (de)
IL (1) IL104828A (de)
TW (1) TW241260B (de)
WO (1) WO1993016997A1 (de)
ZA (1) ZA931261B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU666318B2 (en) * 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US6867310B1 (en) 1997-11-20 2005-03-15 Massachusetts Institute Of Technology Arylation and vinylation of activated carbons
ES2209728T3 (es) * 1999-08-06 2004-07-01 F. Hoffmann-La Roche Ag Tetrahidro-benzo(d)azepinas y su uso como antagonistas de receptores de glutamato metabotropico.
EP1274744A2 (de) 2000-04-13 2003-01-15 E.I. DUPONT DE NEMOURS AND COMPANY, Legal Patent Records Center Polymerträger-herstellungsverfahren von heteroatom-bidentatliganden und verwendung zur katalyse
NZ540148A (en) 2002-12-20 2007-11-30 Glaxo Group Ltd Benzazepine derivatives for the treatment of neurological disorders
HUE028976T2 (en) 2003-06-17 2017-02-28 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
ZA200701232B (en) 2004-07-15 2008-08-27 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ， インコーポレイテッド ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
CN101547892B (zh) 2006-12-05 2014-08-20 艾尼纳制药公司 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
WO2010132437A1 (en) 2009-05-12 2010-11-18 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
JP5739415B2 (ja) 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用
CA2760837C (en) * 2009-05-12 2018-04-03 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
SG10201506870PA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Salts of lorcaserin with optically active acids
EP2611433A2 (de) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Nicht-hygroskopische salze aus 5-ht2c-agonisten
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
KR20150070249A (ko) 2012-10-09 2015-06-24 아레나 파마슈티칼스, 인크. 체중 관리 방법
WO2015153683A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
WO2021213353A1 (zh) * 2020-04-20 2021-10-28 苏州恩华生物医药科技有限公司 酰胺或者磺酰胺类衍生物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015639A (en) * 1987-03-27 1991-05-14 Schering Corporation Substituted benzazepines, their preparation and pharmaceutical compositions containing them
ZA882080B (en) * 1987-03-27 1989-04-26 Schering Corp Substituted benzazepines,their preparation and pharmaceutical compositions containing them
DE3936594A1 (de) * 1989-09-15 1991-03-28 Basf Ag (gamma)-glutamyl-transferasen zur behandlung von krankheiten
IL98487A0 (en) * 1990-06-15 1992-07-15 Schering Corp 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substituted benzazepines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU3722193A (en) 1993-09-13
TW241260B (de) 1995-02-21
EP0628030A1 (de) 1994-12-14
WO1993016997A1 (en) 1993-09-02
ES2183810T3 (es) 2003-04-01
CA2130797C (en) 2006-07-04
EP0628030B1 (de) 2002-12-11
JPH07504196A (ja) 1995-05-11
IL104828A0 (en) 1993-06-10
CA2130797A1 (en) 1993-08-26
IL104828A (en) 1999-08-17
DE69332559T2 (de) 2003-11-20
ZA931261B (en) 1993-08-23
US5241065A (en) 1993-08-31
DE69332559D1 (de) 2003-01-23
US5530125A (en) 1996-06-25

Similar Documents

Publication Publication Date Title
ATE229510T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepinen mit anti- psychotisch wirkung, und synthese von alfa- substituierten-arylacetamiden
CA2242351A1 (en) Novel tricyclic compounds and drug compositions containing the same
Katritzky et al. The chemistry of benzotriazole. Part 8. A novel two-step procedure for the N-alkylation of amides
TW200420569A (en) New ruthenium complexes as (pre)catalysts for the metathesis reaction, 2-alkoxy-5-nitrostyrene derivatives as intermediates and the method of their manufacturing
MY131574A (en) Method for producing catalysts consisting of metal of the platinum group by means of electroless deposition and the use thereof for the direct synthesis of hydrogen peroxide
HUP0002058A2 (hu) Eljárás és katalizátor hidrogénátvivő hidrogénezésre
CA2141048A1 (en) Substituted benzylamino nitrogen containing non-aromatic heterocycles
HUP0004664A2 (hu) Eljárás acilezett gyűrűs 1,3-dikarbonil-vegyületek előállítására
TW342399B (en) Preparation of supported transition metal catalysts
AU6471200A (en) Substituted aromatic-ring compounds, process for producing the same, and use
MY118605A (en) Process for the preparation of a thiazolidinedione derivative
EP0567090A3 (de)
KR970001347A (ko) 벤즈이소티아졸릴 치환 아미노메틸크로만
KR970065532A (ko) 고리형 n-비닐 카르복실산 아미드의 제조 방법
DE69820481D1 (de) Verfahren zur herstellung von cholecalciferol-derivaten und zwischenverbindungen
Krantz et al. Preparation of 1, 3-oxazin-6-one. Potential precursor to azacyclobutadiene
BR9407271A (pt) Beta-aminovinilcetonas processo de preparação e utilização das mesmas
ATE279191T1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
Pastor et al. Conjugate addition of N, N-dialkylhydroxylamines. Mechanism of O-alkylation by 1H-pyrrole-2, 5-diones
Hirokami et al. Photochemistry of 4-pyrimidinones: isolation of Dewar isomers
IE45889L (en) 4-AMINO-BENZO (b) BICYCLO [3.3.1] NONENE DERIVATIVES,¹ANTI-DEPRESSANTS
EP0619294A4 (de) Verfahren zur Herstellung von 1-Phenoxy-2-aminopropan.
Mizutani et al. Palladium-catalyzed polyhetero-claisen rearrangement of 4-allylthiopyrimidin-2 (1h)-ones and 5-allylthio-1, 2, 4-triazin-3 (2h)-ones
EP0976731A4 (de) Verfahren zur herstellung von 5-methylindolinen
TW326043B (en) Method for preparing coumarin and derivatives thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties